NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Not a good comparison Hankmanhub. Within the next 3-5 years, Seagen's
technological accomplishments will amount to a fraction of the life saving
technology that will be introduced by NWBO and that difference will also be
reflected in both companies' MC or the MC of the entities who purchase those
two companies.

Unless some other extremely efficacious cancer treatment can be rapidly
developed and introduced into the market, DCVax is going to be the next
major treatment for most solid cancers because to date, both DCVax-L and
D have shown in their respective trials, a substantial efficacy and smaller
combo trials utilizing DCVax-L with adjuvants (poly-ICLC, keytruda) are showing
an ever increasing life extending capacity.

There is therefore overwhelming evidence from several trials and RWE
(compassionate patients) that DCVax works and will likely improve.

The only major questions remaining are:
1. Right after MHRA approval, how long will NWBO carry the burden alone or will there be soon
thereafter a partnership or BO?
2. The relative difficulty involved ( time and expenses) to bring the treatments to patients with GBM
and later to patients with other solid cancers while NWBO is working alone, with partnership or a BO?
3. When can the Edens automatic manufacturing system be validated and how will that system affect
questions 1 and 2?